These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7298785)

  • 1. Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of high-performance liquid chromatography.
    Pickup ME; Lowe JR; Galloway DB
    J Chromatogr; 1981 Oct; 225(2):493-7. PubMed ID: 7298785
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of tenoxicam in human plasma by high-performance liquid chromatography.
    Heizmann P; Körner J; Zinapold K
    J Chromatogr; 1986 Jan; 374(1):95-102. PubMed ID: 3485110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatographic assay of isoxicam in human plasma and urine.
    Bury RW
    J Chromatogr; 1985 Jan; 337(1):156-9. PubMed ID: 3980647
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatography.
    Dixon JS; Lowe JR; Galloway DB
    J Chromatogr; 1984 Oct; 310(2):455-9. PubMed ID: 6511864
    [No Abstract]   [Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of isoxicam in human plasma and urine.
    Daftsios AC; Johnson EL; Keeley FJ; Gryczko C; Rawski V
    J Chromatogr; 1984 Jan; 305(1):145-51. PubMed ID: 6707138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of piroxicam in plasma by high-performance liquid chromatography.
    Twomey TM; Bartolucci SR; Hobbs DC
    J Chromatogr; 1980 Jul; 183(1):104-8. PubMed ID: 7400257
    [No Abstract]   [Full Text] [Related]  

  • 7. Liquid chromatographic determination of piroxicam in serum.
    Fraser AD; Woodbury JF
    Ther Drug Monit; 1983 Jun; 5(2):239-42. PubMed ID: 6879650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.
    Ji HY; Lee HW; Kim YH; Jeong DW; Lee HS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):214-9. PubMed ID: 16169293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
    Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance thin-layer chromatographic assay for the routine determination of piroxicam in plasma, urine and tissue.
    Riedel KD; Laufen H
    J Chromatogr; 1983 Aug; 276(1):243-8. PubMed ID: 6672021
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of meloxicam by high-performance liquid chromatography with cloud-point extraction.
    Zhang H; Choi HK
    Anal Bioanal Chem; 2008 Nov; 392(5):947-53. PubMed ID: 18751683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-tandem mass spectrometry method for the determination of meloxicam and its metabolite 5-carboxymeloxicam in human plasma.
    Lee HW; Ji HY; Kim HY; Lee KC; Lee HS
    Bioanalysis; 2009 Apr; 1(1):63-70. PubMed ID: 21083189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isoxicam: physicochemical characteristics and the quantitative determination by HPLC].
    Marini D; Pollino G
    Boll Chim Farm; 1984 Mar; 123(3):124-32. PubMed ID: 6743393
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of administration of propranolol on the pharmacokinetics of isoxicam.
    Caillé G; Larivière L; Lacasse Y; Vézina M; Besner JG
    Biopharm Drug Dispos; 1986; 7(1):63-9. PubMed ID: 3955200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood levels and therapeutic effectiveness of piroxicam as affected by the time of administration].
    Kullich W; Wottawa A; Klein G
    Arzneimittelforschung; 1985; 35(9):1477-9. PubMed ID: 4084349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry.
    Shirako J; Kawasaki M; Komine K; Kunisue Y; Terada M; Sasaki C; Irie W; Murakami C; Tonooka K; Tomobe K; Shinozuka T
    Forensic Sci Int; 2013 Apr; 227(1-3):100-2. PubMed ID: 23273940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of leukocyte peroxidases in the metabolism of tenoxicam.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M
    Biochem Pharmacol; 1985 Apr; 34(8):1337-8. PubMed ID: 2986643
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective method for the detection of piroxicam in human plasma using HPLC.
    Calvo AM; Prado MT; Dionísio TJ; Marques MP; Brozoski DT; Lanchote VL; Faria FA; Santos CF
    Braz Oral Res; 2016 May; 30(1):. PubMed ID: 27223141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of sulthiame in plasma by high-performance liquid chromatography.
    Sadanaga T; Hikida K; Tameto K; Nakanishi M; Matsushima Y; Ohkura Y
    Chem Pharm Bull (Tokyo); 1981 Mar; 29(3):872-4. PubMed ID: 6113899
    [No Abstract]   [Full Text] [Related]  

  • 20. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
    Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
    Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.